Research Article
Viral Agents Causing Acute Respiratory Infections in Children under Five: A Study from Eastern India
Table 1
Isolation of viruses (monoinfection versus coinfection) in children with ARIs.
| | Viruses | Total | Monoinfection | Coinfection | | 2–6 mo | >6–12 mo | >12–60 mo | 2–6 mo | >6–12 mo | >12–60 mo |
| | Acute URI (percentage) () | | RSV | 18 (17) | 3 (2.8) | 7 (6.6) | 4 (3.8) | 0 | 1 (0.9) | 3 (2.8) | | RSVA | 13 (12.3) | 2 (1.9) | 5 (4.7) | 3 (2.8) | 0 | 1 (0.9) | 2 (1.9) | | RSVB | 5 (4.7) | 1 (0.9) | 2 (1.9) | 1 (0.9) | 0 | 0 | 1 (0.9) | | ADV | 20 (18.9) | 0 | 2 (1.9) | 7 (6.6) | 1 (0.9) | 2 (1.9) | 8 (7.6) | | RV | 33 (31.1) | 3 (2.8) | 8 (7.6) | 11 (10.4) | 1 (0.9) | 6 (5.7) | 4 (3.8) | | IFV | 18 (17) | 1 (0.9) | 4 (3.8) | 6 (5.7) | 0 | 3 (2.8) | 4 (3.8) | | IFVA | 15 (14.2) | 1 (0.9) | 3 (2.8) | 5 (4.7) | 0 | 3 (2.8) | 3 (2.8) | | IFVB | 3 (2.8) | 0 | 1 (0.9) | 1 (0.9) | 0 | 0 | 1 (0.9) | | hMPV | 6 (5.7) | 0 | 1 (0.9) | 3 (2.8) | 0 | 0 | 2 (1.9) | | hBoV | 4 (3.8) | 0 | 0 | 2 (1.9) | 0 | 1 (0.9) | 1 (0.9) | | PIV | 7 (6.6) | 0 | 1 (0.9) | 2 (1.9) | 0 | 2 (1.9) | 2 (1.9) | | PIV1 | 2 (1.9) | 0 | 0 | 0 (0.9) | 0 | 1 (0.9) | 1 (0.9) | | PIV2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | PIV3 | 5 (4.7) | 0 | 1 (0.9) | 2 (0.9) | 0 | 1 (0.9) | 1 (0.9) | | PIV4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | hCoV 43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | EV | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| | Acute LRI (percentage) () | | RSV | 43 (30.3) | 16 (11.3) | 9 (6.3) | 3 (2.1) | 3 (2.1) | 7 (5.0) | 5 (3.5) | | RSVA | 17 (12) | 4 (2.8) | 5 (3.5) | 1 (0.7) | 2 (1.4) | 4 (2.8) | 1 (0.7) | | RSVB | 26 (18.3) | 12 (8.5) | 4 (2.8) | 2 (1.4) | 1 (0.7) | 3 (2.1) | 4 (2.8) | | ADV | 19 (13.4) | 1 (0.7) | 3 (2.1) | 7 (5.0) | 0 | 3 (2.1) | 5 (3.5) | | RV | 21 (14.8) | 2 (1.4) | 5 (3.5) | 7 (5.0) | 1 (0.7) | 2 (1.4) | 4 (2.8) | | IFV | 25 (17.6) | 2 (1.4) | 5 (3.5) | 8 (5.6) | 1 (0.7) | 4 (2.8) | 5 (3.5) | | IFVA | 17 (12) | 2 (1.4) | 4 (2.8) | 6 (4.2) | 1 (0.7) | 2 (1.4) | 2 (1.4) | | IFVB | 8 (5.6) | 0 | 1 (0.7) | 2 (1.4) | 0 | 2 (1.4) | 3 (2.1) | | hMPV | 8 (5.6) | 0 | 1 (0.7) | 3 (2.1) | 0 | 2 (1.4) | 2 (1.4) | | hBoV | 7 (4.9) | 0 | 1 (0.7) | 2 (1.4) | 0 | 1 (0.7) | 3 (2.1) | | PIV | 15 (10.5) | 1 (0.7) | 4 (2.8) | 4 (2.8) | 1 (0.7) | 3 (2.1) | 2 (1.4) | | PIV1 | 5 (3.5) | 0 | 1 (0.7) | 1 (0.7) | 0 | 1 (0.7) | 2 (1.4) | | PIV2 | 1 (0.7) | 0 | 0 | 1 (0.7) | 0 | 0 | 0 | | PIV3 | 7 (4.9) | 1 (0.7) | 2 (1.4) | 2 (1.4) | 1 (0.7) | 1 (0.7) | 0 | | PIV4 | 2 (1.4) | 0 | 1 (0.7) | 0 | 0 | 1 (0.7) | 0 | | hCoV 43 | 3 (2.1) | 0 | 1 (0.7) | 1 (0.7) | 0 | 0 | 1 (0.7) | | EV | 1 (0.7) | 0 | 0 | 0 | 0 | 0 | 1 (0.7) |
|
|
RSV: respiratory syncytial virus; ADV: adenovirus; RV: rhinovirus; IFV: influenza virus; hMPV: human metapneumovirus; hBoV: human bocavirus; PIV: parainfluenza virus; hCoV 43: human corona virus 43; EV: enterovirus; ARI: acute respiratory infection; URI: upper respiratory infection; LRI: lower respiratory infection.
|
